Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents
暂无分享,去创建一个
[1] J. Stephens,et al. An update on visfatin/pre-B cell colony-enhancing factor, an ubiquitously expressed, illusive cytokine that is regulated in obesity , 2006, Current opinion in lipidology.
[2] A. Guse. Second messenger function and the structure–activity relationship of cyclic adenosine diphosphoribose (cADPR) , 2005, The FEBS journal.
[3] R. Stevens,et al. The structure of a eukaryotic nicotinic acid phosphoribosyltransferase reveals structural heterogeneity among type II PRTases. , 2005, Structure.
[4] A. Vidal-Puig,et al. Visfatin: the missing link between intra-abdominal obesity and diabetes? , 2005, Trends in molecular medicine.
[5] Sung-Hou Kim,et al. Crystal Structure of a Nicotinate Phosphoribosyltransferase from Thermoplasma acidophilum* , 2005, Journal of Biological Chemistry.
[6] J. Koutcher,et al. Metabolic Signatures Associated with a NAD Synthesis Inhibitor–Induced Tumor Apoptosis Identified by 1H-Decoupled-31P Magnetic Resonance Spectroscopy , 2005, Clinical Cancer Research.
[7] R. Huber,et al. Structures of Escherichia coli NAD Synthetase with Substrates and Products Reveal Mechanistic Rearrangements* , 2005, Journal of Biological Chemistry.
[8] S. Eom,et al. Crystal structure of NH3‐dependent NAD+ synthetase from Helicobacter pylori , 2005, Proteins.
[9] L. Guarente,et al. Calorie Restriction— the SIR2 Connection , 2005, Cell.
[10] H. Lodish,et al. Visfatin: A New Adipokine , 2005, Science.
[11] M. Matsuda,et al. Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin , 2005, Science.
[12] S. Imai,et al. The NAD Biosynthesis Pathway Mediated by Nicotinamide Phosphoribosyltransferase Regulates Sir2 Activity in Mammalian Cells* , 2004, Journal of Biological Chemistry.
[13] R. Marmorstein. Structure and chemistry of the Sir2 family of NAD+-dependent histone/protein deactylases. , 2004, Biochemical Society transactions.
[14] J. Milbrandt,et al. Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration , 2004, Science.
[15] Max Hasmann,et al. FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. , 2003, Cancer research.
[16] B. Rattel,et al. Antiangiogenic potency of FK866/K22.175, a new inhibitor of intracellular NAD biosynthesis, in murine renal cell carcinoma. , 2003, Anticancer research.
[17] H. Fujisawa,et al. Growth phase‐dependent changes in the subcellular localization of pre‐B‐cell colony‐enhancing factor 1 , 2003, FEBS letters.
[18] D. Gigot,et al. Pre‐B‐cell colony‐enhancing factor, whose expression is up‐regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis , 2002, European journal of immunology.
[19] J. Arends,et al. Target validation for genomics using peptide‐specific phage antibodies: A study of five gene products overexpressed in colorectal cancer , 2002, International journal of cancer.
[20] N. Grishin,et al. Structure of Human Nicotinamide/Nicotinic Acid Mononucleotide Adenylyltransferase , 2002, The Journal of Biological Chemistry.
[21] B. Rattel,et al. WK175, a novel antitumor agent, decreases the intracellular nicotinamide adenine dinucleotide concentration and induces the apoptotic cascade in human leukemia cells. , 2002, Cancer research.
[22] G Jogl,et al. COMO: a program for combined molecular replacement. , 2001, Acta crystallographica. Section D, Biological crystallography.
[23] M. Ziegler. New functions of a long-known molecule. Emerging roles of NAD in cellular signaling. , 2000, European journal of biochemistry.
[24] J. Arends,et al. A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization , 1999, FEBS letters.
[25] Russ Miller,et al. The design and implementation of SnB version 2.0 , 1999 .
[26] J C Sacchettini,et al. Crystal structure of quinolinic acid phosphoribosyltransferase from Mmycobacterium tuberculosis: a potential TB drug target. , 1998, Structure.
[27] R J Read,et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.
[28] C. Grubmeyer,et al. Kinetic mechanism of nicotinic acid phosphoribosyltransferase: implications for energy coupling. , 1998, Biochemistry.
[29] G. Murshudov,et al. Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.
[30] J C Sacchettini,et al. A new function for a common fold: the crystal structure of quinolinic acid phosphoribosyltransferase. , 1997, Structure.
[31] C. Grubmeyer,et al. Energy coupling in Salmonella typhimurium nicotinic acid phosphoribosyltransferase: identification of His-219 as site of phosphorylation. , 1996, Biochemistry.
[32] Collaborative Computational,et al. The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.
[33] I McNiece,et al. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor , 1994, Molecular and cellular biology.
[34] S V Evans,et al. SETOR: hardware-lighted three-dimensional solid model representations of macromolecules. , 1993, Journal of molecular graphics.
[35] W. Hendrickson. Determination of macromolecular structures from anomalous diffraction of synchrotron radiation. , 1991, Science.
[36] J. Zou,et al. Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.
[37] W A Hendrickson,et al. Selenomethionyl proteins produced for analysis by multiwavelength anomalous diffraction (MAD): a vehicle for direct determination of three‐dimensional structure. , 1990, The EMBO journal.
[38] Mike Carson,et al. Ribbon models of macromolecules , 1987 .
[39] G. Magni,et al. Enzymology of NAD+ homeostasis in man , 2003, Cellular and Molecular Life Sciences CMLS.
[40] Thomas C Terwilliger,et al. SOLVE and RESOLVE: automated structure solution and density modification. , 2003, Methods in enzymology.
[41] Z. Otwinowski,et al. [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.